Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Tuberculosis

  Free Subscription


13.09.2021

1 Clin Infect Dis
2 J Immunol
3 PLoS Med
3 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Clin Infect Dis

  1. ACHARYA MP, Pradeep SP, Murthy VS, Chikkannaiah P, et al
    CD38+CD27-TNF-alpha + on Mtb-specific CD4+ T Cells Is a Robust Biomarker for Tuberculosis Diagnosis.
    Clin Infect Dis. 2021;73:793-801.
    PubMed         Abstract available


    J Immunol

  2. BERNARD-RAICHON L, Colom A, Monard SC, Namouchi A, et al
    A Pulmonary Lactobacillus murinus Strain Induces Th17 and RORgammat(+) Regulatory T Cells and Reduces Lung Inflammation in Tuberculosis.
    J Immunol. 2021 Sep 3. pii: jimmunol.2001044. doi: 10.4049/jimmunol.2001044.
    PubMed         Abstract available

  3. BUNJUN R, Omondi FMA, Makatsa MS, Keeton R, et al
    Th22 Cells Are a Major Contributor to the Mycobacterial CD4(+) T Cell Response and Are Depleted During HIV Infection.
    J Immunol. 2021 Aug 13. pii: jimmunol.1900984. doi: 10.4049/jimmunol.1900984.
    PubMed         Abstract available


    PLoS Med

  4. MACPHERSON P, Webb EL, Kamchedzera W, Joekes E, et al
    Computer-aided X-ray screening for tuberculosis and HIV testing among adults with cough in Malawi (the PROSPECT study): A randomised trial and cost-effectiveness analysis.
    PLoS Med. 2021;18:e1003752.
    PubMed         Abstract available

  5. BASTOS ML, Melnychuk L, Campbell JR, Oxlade O, et al
    The latent tuberculosis cascade-of-care among people living with HIV: A systematic review and meta-analysis.
    PLoS Med. 2021;18:e1003703.
    PubMed         Abstract available

  6. AULD AF, Kerkhoff AD, Hanifa Y, Wood R, et al
    Derivation and external validation of a risk score for predicting HIV-associated tuberculosis to support case finding and preventive therapy scale-up: A cohort study.
    PLoS Med. 2021;18:e1003739.
    PubMed         Abstract available


    PLoS One

  7. JO Y, Kagujje M, Johnson K, Dowdy D, et al
    Costs and cost-effectiveness of a comprehensive tuberculosis case finding strategy in Zambia.
    PLoS One. 2021;16:e0256531.
    PubMed         Abstract available

  8. NGOC NB, Vu Dinh H, Thuy NT, Quang DV, et al
    Active surveillance for adverse events in patients on longer treatment regimens for multidrug-resistant tuberculosis in Viet Nam.
    PLoS One. 2021;16:e0255357.
    PubMed         Abstract available

  9. GOTHAM D, McKenna L, Deborggraeve S, Madoori S, et al
    Public investments in the development of GeneXpert molecular diagnostic technology.
    PLoS One. 2021;16:e0256883.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: